Despite the initial downturn in the stock market following the New Year, several biotech stocks are poised for a strong 2016. Maintaining a healthy understanding of these stocks should help you set yourself up nicely for a healthy return on investment. While there are dozens of biotech stocks looking to make strong movement in the coming months, here are several to consider. Retrophin, Inc (RTRX) This company specializes in the development, acquisition and production of specialized drugs designed to treat rare diseases. With the progress of medical science over the last several years, this specific sector of the industry...

Biotechs/Pharma and Economic Slumps Remarks by Democratic Party presidential hopeful Hilary Clinton that she would change drug pricing if elected in 2016 caused a major sell off wave by biotech companies in the last half of 2015. Though prices of stocks went up towards the end of the year, it raised concern over the ability of the biotech sector to hold up during a market slump. Funds which invested in biotech firms were some of the hardest hit by the sell off, one of them being Woodford Patient Capital Trust. It lost 6.2% in net asset value in the...

Since the economy went sideways in 2008 the stock market seems to have a tarnished image. One area of investment that is helping investors feel good about what they are doing is Biotech. The three sectors of the biotech industry that have done well and will continue to do well moving farther into the 21st century are 3D Printing, Nanotechnology, and Pharmaceuticals. Many experts predict this market will grow to several hundred billion over the decade. The great thing about these companies is that while they create a lot of value as an investment they also create a lot...

A look at the Massachusetts Life Sciences index snapshot reveals a number of gainers in the market, including Espirius BioPharma (EPRS), Catabassis Pharma (CATB), Histogenics Corp. (HSGX), InspireMD Inc. (NSPR), Minerva Neuroscience (NERV), Invivo Theapeutic (NVIV), Curis Inc. (CRIS), Agenus Inc. (AGEN), Agios Pharmaceutical (AGIO), and Abiomed Inc. (ABMD). Some of these are edging in and out of gain. There’s some substantial flux right now, and it’s no wonder. On Wednesday there will be a panel discussion at the Biotechnology Council’s breakfast event in regard to policy leadership. At the conference will be over three hundred executives from such...

If you blinked over the last week and weren’t monitoring the latest stock movements, you might have missed Codexis, Inc (CDXS). While most industry analysts were commenting on the drop off in early year training, there were several movers and shakers, including Codex. With an eight percent rise on Friday, the company is starting to push in a strong performance over the last week and a half. As many stocks, it dropped off right at the end of the year as investors attempted to prepare for the 2016 tax season. Since the late 2015/early 2016 sell off period though,...